Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
A legfontosabb adatok
- Ki végzi
- Medical University of South Carolina
- Hol
- Charleston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Fázis
- Korai 1. fázis
- Résztvevők
- 15 fő vett részt
- Kezdés
- 2024. aug. 6.
- Befejezés
- 2026. jan. 13.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Empowering Pregnant Women and People Receiving Medications for Opioid Use Disorder
- A regiszteradat frissítve
- 2026. március 27.
Ki vehet részt
- Életkor
- 18 év – 45 év
- Nem
- Csak nők
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Currently pregnant and less than 33 weeks gestational age,
- History of OUD within past 3 years,
- Confirmed prescription for sublingual buprenorphine products (i.e., Suboxone, Subutex, Zubsolv) for the purpose of treating OUD,
- Living in the United States,
- Between 18-45 years of age
Ki nem vehet részt
- High-risk pregnancies including the following conditions: hyperemesis defined as hospitalization for intractable nausea and vomiting, hypertensive disorders of pregnancy (e.g., gestational hypertension, preeclampsia), placenta previa, or vaginal bleeding in current pregnancy after the first trimester
- Experiencing cognitive or emotional impairment that precludes providing informed consent
- Carrying multiples (i.e., twins, triplets, etc.)
- Current psychotic symptoms and/or active suicidal intent
- Incarcerated/pending incarceration or institutionalized during the study period
Helyszínek itt: Egyesült Államok
- Medical University of South CarolinaCharleston, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study involves testing how useful a technology-enhanced intervention is for pregnant people prescribed buprenorphine for the management of opioid use disorder. The intervention being studied is a brief therapy protocol and a mobile application. Participation involves four 60-minute therapy appointments during pregnancy, and four 30-minute therapy appointments at the end of pregnancy through 3 months postpartum. The mobile application will be accessible for at least the duration of the study. Participants will also be asked to complete questionnaires at enrollment and again at 1-month postpartum and 3-months postpartum, will send monthly photos of their prescription bottle/box, and will be contacted randomly throughout the study to perform a medication count. The total duration of the study is between 5-9 months depending on when you enroll (early second trimester-mid third trimester). Compensation is provided.
A vizsgálat csoportja
- Empowering Pregnant Women and People Receiving Medications for Opioid Use DisorderA vizsgált kezelés
EMPWR is a two-pronged intervention model comprised of 1) a provider-driven, telemedicine-based behavioral intervention to mitigate anxiety sensitivity and sleep deficiency and enhance peripartum buprenorphine retention, and 2) an adjunctive mobile application to promote patients' buprenorphine adherence and use of therapy skills learned through the behavioral intervention. The EMPWR therapy protocol is comprised of five 30-60-minute sessions delivered weekly or biweekly by a therapist during the second and/or third trimester of pregnancy, and three 30-minute booster sessions delivered months 1-3 postpartum.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- EMPWR Pilot Trial: Treatment Retention in Medication for Opioid Use Disorder Among Pregnant and Postpartum Women
- A regiszteradat frissítve
- 2026. március 27.